Vaccines | Free Full-Text | Nanoalum Formulations Containing Aluminum Hydroxide and Cpg 1018TM Adjuvants: The Effect on Stability and Immunogen-Icity of a Recombinant SARS-CoV-2 Rbd Antigen
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
Frontiers | Adjuvant Effect of Toll-Like Receptor 9 Activation on Cancer Immunotherapy Using Checkpoint Blockade
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus | SpringerLink
Targeting natural killer cells to enhance vaccine responses: Trends in Pharmacological Sciences
Sequence List of CpG-C ODNs | Download Table
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
CpG-C ODN M362 as an immunoadjuvant for HBV therapeutic vaccine reverses the systemic tolerance against HBV
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19 | Scientific Reports
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Development of the CpG Adjuvant 1018: A Case Study | SpringerLink
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
SARS-CoV-2 receptor binding domain displayed on HBsAg virus–like particles elicits protective immunity in macaques | Science Advances
CpG oligodeoxynucleotide - Wikipedia
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses - ScienceDirect
Spatially Controlled Activation of Toll-like Receptor 9 with DNA-Based Nanomaterials | Nano Letters
Publikationen von Prof. Jeltsch | Institut für Biochemie und Technische Biochemie | Universität Stuttgart
Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues | Protocol (Translated to German)
Frontiers | Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
A CpG 1018 adjuvanted neuraminidase vaccine provides robust protection from influenza virus challenge in mice | npj Vaccines
Vaccines | Free Full-Text | CpG 1018 Is an Effective Adjuvant for Influenza Nucleoprotein
Frontiers | Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21
Optimization, Production, and Characterization of a CpG-Oligonucleotide-Ficoll Conjugate Nanoparticle Adjuvant for Enhanced Immunogenicity of Anthrax Protective Antigen | Bioconjugate Chemistry
Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years - ScienceDirect
Frontiers | CpG Adjuvant in Allergen-Specific Immunotherapy: Finding the Sweet Spot for the Induction of Immune Tolerance
